10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 268 filers reported holding 10X GENOMICS INC in Q4 2022. The put-call ratio across all filers is 0.96 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $588,665 | +13.2% | 10,542 | +13.1% | 0.00% | 0.0% |
Q1 2023 | $519,851 | +152797.4% | 9,318 | 0.0% | 0.00% | – |
Q4 2022 | $340 | -100.0% | 9,318 | -95.6% | 0.00% | -100.0% |
Q2 2022 | $9,484,000 | -45.7% | 209,595 | -8.8% | 0.01% | -35.0% |
Q1 2022 | $17,476,000 | -55.8% | 229,736 | -13.4% | 0.02% | -48.7% |
Q4 2021 | $39,506,000 | +96.9% | 265,215 | +92.5% | 0.04% | +77.3% |
Q3 2021 | $20,060,000 | – | 137,793 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Foresite Capital Management II, LLC | 1,358,528 | $49,504,760 | 100.00% |
Meritech Capital Associates V L.L.C. | 1,061,682 | $38,687,692 | 9.44% |
Decheng Capital Management III (Cayman), LLC | 359,554 | $13,102,148 | 4.90% |
Sands Capital Ventures, LLC | 481,770 | $17,556 | 4.81% |
Whitford Management LLC | 58,310 | $2,124,803 | 2.88% |
FINANCIAL CONSULATE, INC | 156,457 | $5,701,293 | 1.99% |
SRS Investment Management, LLC | 3,005,427 | $109,517,760 | 1.98% |
BRANDYWINE MANAGERS, LLC | 11,208 | $408,420 | 1.43% |
ARK Investment Management | 4,316,567 | $157,295,701 | 1.36% |
Nikko Asset Management Americas, Inc. | 2,177,988 | $79,365,883 | 1.14% |